Accelerated Neuromodulation to Alleviate Cognitive Deficits Due to Cancer Therapy

Inclusion Criteria: * Women or men with a history of non-metastatic cancer who have completed definitive curative cancer therapy * Received cytotoxic chemotherapy as a part of their therapy for cancer and at least one month has passed since the final cytotoxic chemotherapy treatment * ≥ 18 years of age at time of cancer diagnosis and receipt of chemotherapy * Patients must report subjective symptoms of "chemo-brain" (memory loss, difficulty with concentration, word-finding difficulties) with a FACT-Cog perceived cognitive impairment score \< 60 * Ability to sign informed consent and comply with study procedures Exclusion Criteria: * Patients with a recurrence of cancer or those with current metastatic disease * Patients with a history or current diagnosis of brain metastasis * Patients with a history or current diagnosis of a primary brain tumor * Patients with a history of brain surgery or brain radiation * Patients receiving maintenance systemic therapy for cancer, other than endocrine therapy * Patients who cannot produce or request adequate medical record documentation to ensure they meet inclusion and exclusion criteria * Women who are currently pregnant * History of childhood cancer or receipt of chemotherapy in childhood (\<age 18). Developmental insult to the PFC, can be associated with long-term, durable and sometime debilitating cognitive deficits. Hence, we avoid any cognitive confounds that maybe related to this issue. * Patients with a weight over 250 lbs., as…